Study Finds Room for Improvement in Use of Breast MRI
In 4 years, the rate of women receiving breast MRI nearly tripled, but it is underused in women most at risk for breast cancer and overused in women at average risk.
FDA Approves First Treatment for Neoadjuvant Breast Cancer
Accelerated approval of Perjeta (pertuzumab) was granted by the FDA as part of a complete treatment regimen for patients with early stage breast cancer before surgery.
Navigating Breast Density Laws
Breast density laws ensure that women receive critical breast-health information, supporters say, but many of the laws broadly classify breast density and fail to account for varying levels of risk.
10-Year Data Supports Shorter Radiotherapy for Breast Cancer
The use of 40 Gy in 15 fractions over 3 weeks is as effective and causes less damage to nearby tissue than a higher total dose of radiotherapy for breast cancer.
Do We Need Mammograms for Breast Cancer Screening?
Researchers suggest that recommendations for the universal screening of breast cancer with mammography be reassessed.
Postmenopausal Breast Cancer Survivors at Greater Risk for Metabolic Syndrome
Metabolic syndrome is more likely to develop in postmenopausal survivors of breast cancer than in postmenopausal women who never had the disease.
Practice Guidelines for Breast Cancer Follow-Up After Primary Treatment
A review of new publications by the Update Committee for the American Society of Clinical Oncology found that the guidelines for the follow-up and management of patients with breast cancer who have completed treatment are still sound.
By clicking Accept, you agree to become a member of the UBM Medica Community.